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RNA interference (RNAi) is an important mosquito defense mechanism against arbovirus infection. In this
paper we study the processes underlying antiviral RNAi in Aedes albopictus-derived U4.4 mosquito cells infected
with Semliki Forest virus (SFV) (Togaviridae; Alphavirus). The production of virus-derived small interfering
RNAs (viRNAs) from viral double-stranded RNA (dsRNA) is a key event in this host response. dsRNA could
be formed by RNA replication intermediates, by secondary structures in RNA genomes or antigenomes, or by
both. Which of these dsRNAs is the substrate for the generation of viRNAs is a fundamental question. Here we
used deep sequencing of viRNAs and bioinformatic analysis of RNA secondary structures to gain insights into
the characteristics and origins of viRNAs. An asymmetric distribution of SFV-derived viRNAs with notable
areas of high-level viRNA production (hot spots) and no or a low frequency of viRNA production (cold spots)
along the length of the viral genome with a slight bias toward the production of genome-derived viRNAs over
antigenome-derived viRNAs was observed. Bioinformatic analysis suggests that hot spots of viRNA production
are rarely but not generally associated with putative secondary structures in the SFV genome, suggesting that
most viRNAs are derived from replicative dsRNA. A pattern of viRNAs almost identical to those of A. albopictus
cells was observed for Aedes aegypti-derived Aag2 cells, suggesting common mechanisms that lead to viRNA
production. Hot-spot viRNAs were found to be significantly less efficient at mediating antiviral RNAi than
cold-spot viRNAs, pointing toward a nucleic acid-based viral decoy mechanism to evade the RNAi response.
Arboviruses are transmitted to vertebrates by arthropods
such as mosquitoes or ticks (58, 59). The genus Alphavirus
within the family Togaviridae contains medically important
mosquito-borne arboviruses such as chikungunya virus and
Venezuelan equine encephalitis virus (42, 59). The replication
of the prototype alphaviruses Sindbis virus (SINV) and Semliki
Forest virus (SFV) in vertebrate cells is well understood (19,
23, 45). The alphavirus genome is a positive-stranded RNA
with a 5 cap and a 3 poly(A) tail. The 5 two-thirds encodes
the nonstructural polyprotein P1234, which is separated into
four replicase proteins, nsP1 to nsP4, by proteolytic cleavage;
during replication, the genome is transcribed into a full-length
copy (the antigenome), which in turn serves as a template for
the de novo transcription of viral genomes (32, 34, 57). The 3
one-third encodes the structural polyprotein, which is trans-
lated from a subgenomic mRNA and generates the capsid and
envelope glycoproteins after proteolytic processing (54). Al-
phaviruses replicate within cytoplasmic replication complexes
associated with cellular membranes, and viruses mature by
budding (17, 45); important differences in replication complex
formation between vertebrate and mosquito cells have been
described (16). The infection of mosquito cell cultures with
alphaviruses usually starts with an acute phase characterized by
efficient virus production, followed by the establishment of a
persistent infection with low-level virus production (6, 10, 15).
The efficient control of arbovirus infection in insects such as
mosquitoes is believed to be due to innate immune responses,
and alphaviruses such as SFV have proven to be good models
to study these responses (14). The best-characterized mosquito
antiviral defense system to date is RNA interference (RNAi)
(14, 47), which controls arbovirus replication, spread, and
transmission (26, 46). Central to antiviral RNAi in insects
is the production of virus-derived small interfering RNAs
(viRNAs) from viral double-stranded RNA (dsRNA) and the
assembly of an RNA-induced silencing complex (RISC), fol-
lowed by the degradation of target single-stranded viral RNA
in a sequence-dependent manner (14, 25). The origin of the
dsRNA substrate is not clear and could involve double-
stranded regions in single viral genome or antigenome RNA
molecules or two-molecule replication intermediates (the fa-
vored hypothesis) (38). Mosquito orthologues of the Drosoph-
ila melanogaster RNAi proteins Dcr-2, R2D2, and Ago-2 are
important for mosquito RNAi responses against flaviviruses
and alphaviruses (7, 8, 24, 46). In D. melanogaster, the RNase
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III enzyme and DExD/H-box RNA helicase Dcr-2 is a pattern
recognition receptor (PRR) which initiates RNAi by the cleav-
age of virus-derived long dsRNA into double-stranded
viRNAs. Dcr-2 and R2D2 interact during the process of
viRNA generation and integrate viRNAs into the RISC. One
of the viRNA strands (the guide strand; the passenger strand is
degraded) is retained within the RISC, which targets and rec-
ognizes viral single-stranded RNA in a sequence-specific man-
ner and mediates cleavage through the RISC protein Ago-2
(25). In mosquitoes infected with SINV and o’nyong-nyong
virus, the cloning and sequencing of viRNAs showed that
viRNA strands are mainly 21 nucleotides (nt) in length. These
viRNAs map asymmetrically along the complete length of the
virus genome; regions generating a high frequency of viRNAs
(hot spots) and regions generating no or a low frequency of
viRNA (cold spots) are interspersed in an apparently random
manner (38, 39). However, as these infections are nonsynchro-
nized but reflect a mix of cells at various stages of infection, it
is difficult to speculate on the origins of viRNAs. It appears
that arboviruses do not encode protein suppressors of RNAi,
unlike pathogenic insect viruses, many of which encode, for
example, dsRNA-binding proteins that counteract RNAi (14,
25). It has been speculated that an RNAi-suppressive activity
may exist in dengue virus-infected mosquito cells (46). In ad-
dition, it is now known that there is a systemic component to
RNAi responses in insects (3, 44). Little is known with regard
to the biogenesis of arbovirus-derived viRNAs. In the case of
positive-strand RNA viruses or viroids of plants, the predom-
inance of genome-derived viRNAs has led to the suggestion
that secondary structures in the genome are the substrate for
dicer, although replication intermediates have also been impli-
cated (20, 22, 37, 61). For alphaviruses, this remains a topic of
debate, and the substrate for Dcr-2, viral dsRNA, could be
replication intermediates, secondary structures, or both
(14, 38).
Here we show that a synchronized SFV infection of Aedes
albopictus cells induced dsRNA, which colocalizes mainly with
virus nsP proteins in replication complexes. By using deep
sequencing, we observed an asymmetric distribution of SFV-
derived viRNAs with areas of high-level viRNA production
(hot spots) and no or a low frequency of viRNA production
(cold spots) along the length of the viral genome and anti-
genome, with a slight bias toward the production of genome-
derived viRNAs. The infection of A. albopictus- and Aedes
aegypti-derived mosquito cells resulted in almost identical
viRNA production patterns. Hot-spot viRNAs, present at a
high frequency during infection, were found to have only poor
antiviral activity compared to cold-spot viRNAs. This points
toward a nucleic acid-mediated RNAi decoy mechanism pro-
tecting against antiviral RNAi. Bioinformatic analysis of RNA
secondary structures and pairing in the SFV genome (by MFE
[minimal free energy]-based thermodynamic large-scale sec-
ondary structure prediction and StructureDist pairing/second-
ary structure prediction) suggests no general correlation be-
tween the frequency or location of viRNA generation and
putative RNA structures in SFV genomic RNA. This strength-
ens the hypothesis that the origin and production of alphavirus
viRNAs are linked to dsRNA generation during replicative
processes rather than secondary structures in the viral genome.
MATERIALS AND METHODS
Cells, viruses, and infection. A. albopictus-derived U4.4 and A. aegypti-derived
Aag2 mosquito cells were grown at 28°C in L-15 medium with 10% fetal calf
serum and 8% tryptose phosphate broth. The amplification and titration of SFV
(strain SFV4) and clones derived from this virus and infection of U4.4 cells were
carried out as described previously (3). Briefly, SFV4 or derived recombinant
viruses were grown in BHK-21 cells in Glasgow’s minimal essential medium
(GMEM) with 2% newborn calf serum (37°C in a 5% CO2 atmosphere). Details
of the reporter viruses (Fig. 1) used can be obtained from the authors. Viruses
were purified from the supernatant as described previously (12). Virus (resus-
pended in Tris-NaCl-EDTA [TNE] buffer) was titrated by a plaque assay on
BHK-21 cells. For the infection of mosquito cells, viruses were diluted in PBSA
(phosphate-buffered saline [PBS] with 0.75% bovine serum albumin); cells were
infected at 28°C for 1 h and washed twice to remove any unbound particles.
Transfection of hot-spot/cold-spot-derived viRNA mimic siRNAs. siRNA
mimics of SFV viRNAs were produced by Ambion (Table 1). siRNAs for Renilla
luciferase (RLuc) and negative-control siRNA (siRNA 1) were obtained from
Ambion (AM4630 and AM4611). Approximately 1.625  105 U4.4 or 1.6  105
Aag2 cells/well were grown in 24-well plates. Before transfection, the medium
was replaced with fresh complete medium. siRNAs (final concentration, 10 nM)
were mixed with 1 l/well Lipofectamine 2000 (Invitrogen) in Optimem accord-
ing to the manufacturer’s instructions. One hundred microliters of the nucleic
acid-Lipofectamine 2000 complexes was added to 400 l of medium in each well
and incubated for 5 h at 28°C. After transfection, cells were washed twice to
remove liposomes, and complete medium was added. Where indicated, SFV
infection was carried out 24 h after siRNA transfection.
Small RNA isolation and deep sequencing. Total RNA was isolated from U4.4
or Aag2 cells by using Trizol (Invitrogen). Approximately 6.5 105 U4.4 or 8.6
105 Aag2 cells grown in 6-well plates were infected with SFV (multiplicity of
infection [MOI] of 10). Total RNA was extracted at 24 h postinfection (p.i.); the
concentration and purity were determined by using a NanoDrop 1000 instrument
(Thermo Scientific). All subsequent RNA processing was performed at Gene-
Pool, University of Edinburgh (http://genepool.bio.ed.ac.uk/). Small RNAs
smaller than 44 nt were purified from a 15% Tris-borate-EDTA (TBE)–urea
polyacrylamide gel, and RNA adapters were ligated before sequencing according
to the manufacturer’s instructions (Illumina Inc.). Small RNAs were then se-
quenced by using an Illumina Solexa genome analyzer. Small RNAs derived from
uninfected cells were sequenced as a control. To identify SFV-derived viRNAs,
small RNA sequences were compared to the SFV4 reference genome/anti-
genome sequence (GenBank accession number X04129) corrected by the recent
resequencing of SFV4 (GenBank accession number AJ251359) (compiled by A.
Merits, personal communication) using SOAP software (with the help of Gene-
Pool bioinformatics support) (29). Small RNA data as used in the figures within
this paper are shown in Tables S1 to S3 in the supplemental material (Excel
tables), which contain viRNA sequences mapping to the SFV genome or anti-
genome, and both types of viRNAs are separately listed in labeled sheets within
each Excel table;  indicates viRNAs mapping to the SFV genome, and 
indicates viRNAs mapping to the SFV antigenome (sequences complementary to
antigenome viRNAs are shown in a 5-to-3 orientation to simplify mapping; the
viRNA sequence is a complement, reading from left to right, 3 to 5). The
viRNA location/starting position on the SFV genome or antigenome (column B
FIG. 1. Viruses used in this study. (A) SFV (prototype strain
SFV4). (B) SFV4(3F)-eGFP, encoding the eGFP green fluorescent
reporter protein (inserted into to the C-terminal region of nsP3) as
part of the viral nonstructural polyprotein. (C) SFV4(3H)-RLuc, car-
rying the Renilla luciferase (RLuc) reporter gene (flanked by dupli-
cated nsP2-protease cleavage sites at the nsP3/4 junction) as part of the
viral nonstructural polyprotein.
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in Tables S1 to S3), sequence (column C in Tables S1 to S3), frequency (number
of reads; positions from which no viRNA is generated are not shown and are
listed as 0 reads in Table 1) (column D in Tables S1 to S3), and length (nt)
(column E in Tables S1 to S3) are indicated in each sheet (see Table S1 in the
supplemental material for SFV viRNAs from U4.4 cells used in Fig. 3 and 6 and
Fig. S2; see Table S2 in the supplemental material for SFV viRNAs from U4.4
cells used in Fig. 5 and Fig. S1 and S2; and see Table S3 in the supplemental
material for SFV viRNAs from Aag2 cells used in Fig. 4 and 5 and Fig. S1).
Luciferase assays. Cells were lysed in passive lysis buffer (Promega), and
Renilla luciferase (RLuc) activities were measured by using a dual-luciferase
assay (Promega) with a GloMax 20/20 luminometer.
RNA secondary structure prediction. The existence and position of RNA
secondary structures in SFV genomic RNA were predicted by thermodynamic
folding energy calculations that used comparative sequence data from the avail-
able SFV complete genome sequences (SFV4 as described above and GenBank
accession numbers EU350586, DQ189086, and Z48163). This analysis was per-
formed by using the program UNAFold (62). For calculations of folding ener-
gies, sequences in the SFV alignment were split into sets of 150 base fragments
incrementing by 1 base across the genome. Folding energies were compared with
those of 50 copies of each fragment whose sequence order was scrambled using
the algorithm NDR, which preserves dinucleotide frequencies of the native
sequence automated using the program Folding Energy Scan as implemented in
the Simmonic2005 v1.8 package (50). The minimum free energies (MFEs) of
each native sequence fragment were compared with the mean MFE of the
NDR-scrambled controls to produce an MFE difference (MFED) as previously
described (51). MFED values for each fragment were averaged across the 4
available SFV complete genome sequences.
The prediction of specific structures using the available comparative sequence
TABLE 1. Sequences and characteristics of siRNA mimics of hot- and cold-spot-derived viRNAs mapping to the SFV genomea
siRNA or SFV
genome position Sequence
viRNA frequency
(no. of reads) for
U4.4 cells/U4.4
cells/Aag2 cells
Relative RLuc
expression
(%) for U4.4
cells/Aag2 cells
Negative-control siRNAb NA 100
Positive-control RLuc siRNAc NA 30.5/23.8
1016 (cold) 5-GAGGGAUUCCUAGUGUGCAAG-3 0/3/0 21.7/31.2
3-GCCUCCCUAAGGAUCACACGU-5
1268 (hot) 5-UGGGCGAGGGAAUACAAGGCA-3 393/353/253 91.6/103.6
3-UCACCCGCUCCCUUAUGUUCC-5
2257 (hot) 5-UCCGGGAUCAGGCAAGUCUGC-3 341/133/79 60.5/92.7
3-CAAGGCCCUAGUCCGUUCAGA-5
2460 (cold) 5-UCGCUUGCCAUUCCGGUACUC-3 0/0/0 51.8/36.3
3-AAAGCGAACGGUAAGGCCAUG-5
3456 (cold) 5-UCGCAGAAAGAAAAAUCCAAC-3 0/0/0 20.6/39
3-AUAGCGUCUUUCUUUUUAGGU-5
3549 (hot) 5-CGGUUAAAGGCAGUAGGGUUG-3 300/354/261 21.4/42.2
3-GAGCCAAUUUCCGUCAUCCCA-5
5129 (cold) 5-GACUCGUCUUCCACUGCCAGC-3 0/3/0 39/38.1
3-GGCUGAGCAGAAGGUGACGGU-5
6847 (cold) 5-GUUUAUUAACACUGUUUUGAA-3 0/2/0 24.7/41.2
3-AACAAAUAAUUGUGACAAAAC-5
7305 (hot) 5-UGGCGAGGGACAUUAAGGCGU-3 397/256/245 94.1/106.1
3-GAACCGCUCCCUGUAAUUCCG-5
8340 (hot) 5-CGAGGAUAACGUGGAUAGGCC-3 324/1,039/753 97.5/81.4
3-GAGCUCCUAUUGCACCUAUCC-5
9887 (cold) 5-UGCCGAACGUGGUGGGGUUCC-3 0/0/1 43.7/90.2
3-UUACGGCUUGCACCACCCCAA-5
10181 (hot) 5-AGGCGUACGUCGAUCGAUCGG-3 177/848/316 62.2/70.3
3-GCUCCGCAUGCAGCUAGCUAG-5
10499 (hot) 5-ACGACCUGUACGCGAACACGG-3 252/2,744/1,116 89.7/97.7
3-AUUGCUGGACAUGCGCUUGUG-5
10645 (cold) 5-CAAAUCAAAACGAACCCUGUC-3 0/1/1 81.7/102.4
3-CGGUUUAGUUUUGCUUGGGAC-5
a dsRNA duplexes and locations of viRNAs on the SFV genome are shown; the 5 nucleotide of the siRNA top strand indicates the start of the corresponding viRNA
sequence on the SFV genome. viRNA frequencies (read numbers) in U4.4 (see Tables S1 and S2 in the supplemental material) and Aag2 (Table S3) cells are shown
(order of U4.4, U4.4, and Aag2). The average relative RLuc activity (indicator for SFV replication) in the presence of a given siRNA relative to a negative-control
scrambled siRNA (100% RLuc activity) is indicated per cell type (U4.4 or Aag2 cells). NA, not applicable.
b AM4611 (Ambion).
c AM4630 (Ambion).
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data for SFV was done by using the program StructureDist in the Simmonics
package. This program compares minimum energy structures from sequence
data sets and computes phylogenetically conserved pairings and secondary struc-
tures. The results were expressed in the form of pairing frequencies, which is
calculated from the proportion of pairwise comparisons of connect files for each
sequence with the same pairing predictions, as previously described (51).
Immunostaining. U4.4 cells were fixed with 4% paraformaldehyde. After 2
washes (in PBS), cells were permeabilized with 0.3% Triton X-100 in PBS for 20
min and washed twice. After blocking with CAS block (Invitrogen), J2 antibody
(Scicons, Hungary) (in CAS block; 1:400) was added, followed by three washes.
Incubation with secondary antibody (sheep anti-mouse biotinylated IgG [Vector
Labs] in CAS block) was followed by three washes before the addition of strepta-
vidin-conjugated Alexa Fluor 594. After a further two washes, slides were
mounted with mounting medium (Vector Laboratories), and images were ac-
quired (Zeiss AxioSkop confocal microscope).
RESULTS
SFV infection-induced dsRNA colocalizes with virus repli-
cation complexes. U4.4 mosquito cells have functional antiviral
immune responses and resemble infectivity of the mosquito;
the acute phase of SFV infection in these cells lasts up to 24 h
postinfection (p.i.) (3, 15, 35). dsRNA is produced in SINV-
infected mammalian and mosquito cells (53). To determine the
relationship between alphavirus replication complexes and
dsRNA (the trigger of immune responses) in mosquito cells,
A. albopictus-derived U4.4 cells were infected with recombi-
nant SFV4 encoding an nsP3-enhanced green fluorescent pro-
tein (eGFP) fusion protein, SFV(3F)4-eGFP (55) (Fig. 1). The
nsP3-eGFP fusion marks (although not exclusively) viral rep-
lication complexes. At 10 and 24 h p.i., cells were stained with
anti-dsRNA antibody J2, which recognizes dsRNA of more
than 40 bp in length (48, 60). The nsP3-eGFP fusion protein
and dsRNA colocalized into punctate cytoplasmic complexes
(Fig. 2) throughout the acute phase of infection, a distribution
consistent with virus replication on cytoplasmic vacuoles as
described previously for the replication of SFV and other al-
phaviruses in vertebrate and invertebrate cells (15, 16, 45, 52).
This shows that the substrates for dsRNA pattern recognition
are localized predominantly to virus replication vesicles.
The SFV-induced antiviral RNAi response: characterization
and analysis of viRNAs. SFV-derived viRNAs generated dur-
ing the infection of A. albopictus-derived U4.4 cells were char-
acterized at 24 h p.i. by deep sequencing. At an MOI of 10, all
cells in the culture were infected with SFV synchronously; this
FIG. 2. SFV-induced dsRNA is present in mosquito cells and colocalizes with vesicular replication complexes. A. albopictus-derived U4.4
mosquito cells were mock infected or infected with SFV4(3F)-eGFP (in which eGFP is fused to nsP3) (Fig. 1). The green signal marks complexes
made by nsP3-eGFP, including virus replication complexes. Cells were fixed at 10 or 24 h p.i. dsRNA (red signal) was revealed by immunostaining
with dsRNA-specific antibody J2; cell nuclei were labeled with To-Pro3.
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is different from the infection of live mosquitoes, where a mix
of viRNAs from cells at different stages of infection is ob-
tained. RNA molecules below 44 nt were isolated for analysis;
the sequences, frequencies, and locations of viRNAs mapping
to the SFV genome or antigenome described in this and sub-
sequent experiments are indicated in Tables S1 to S3 in the
supplemental material (see Materials and Methods). In total,
3.2 106 small RNA sequences were generated, of which 2.1%
aligned to the SFV sequence. SFV-derived viRNAs were found
to be predominantly 21 nt in length; 21-nt viRNAs accounted
for 91.7% of 21- to 25-nt sequences (see Table S1 in the
supplemental material for details of viRNAs). A total of 55.8%
of the 21-nt viRNAs mapped to the SFV genome, and 35.9%
mapped to the virus antigenomic RNA (Fig. 3A). The 21-nt
viRNAs were scattered over the entire SFV genome and an-
tigenome with a variable frequency (Fig. 3B). Some areas gen-
erated high frequencies of viRNAs (hot spots), and others
generated no (or only very few) viRNAs (cold spots). The
distribution of viRNAs mapping to the genome and anti-
genome appeared largely asymmetric. Sequence analysis of
SFV-aligned viRNAs indicated no obvious skewing toward a
particular base at the first position (28% A, 28% C, 12% G,
and 32% U), no bias in GC content, and no obvious common
sequence motifs. The same pattern was generated for the SFV
replicon region when cells were infected with virus replicon
particles (not shown).
To determine if the host species influences viRNA genera-
tion, an identical study was performed with A. aegypti-derived
Aag2 cells. Aag2 cells were previously shown to mount an
RNAi response to dengue virus infection (46). SFV replicated
to lower titers in Aag2 cells but had a temporal profile of
infectious virus production similar to that which we have de-
scribed previously for U4.4 cells (15). SFV-derived viRNA
sequences in Aag2 cells were determined as described above
for U4.4 cells (see Table S3 in the supplemental material for
viRNA data). A total of 97.6% of viRNAs were 21 nt in length,
similar to U4.4 cells (see above), and the majority of these
viRNAs (58.2%) mapped to the SFV genome, and 39.4%
mapped to the antigenome (Fig. 4A). Again, a very noticeable
distribution of hot- and cold-spot viRNA generation was ob-
served (Fig. 4B). SFV viRNAs obtained from U4.4 cells (as
described in Fig. 3 but from an independent experiment [Table
S2]) were analyzed at the same time as Aag2 viRNAs. The
distribution and profiles of U4.4 cell-derived viRNAs mapping
to the SFV genome or antigenome were compared to Aag2
cell-derived viRNAs mapping to the SFV genome or anti-
genome, respectively. As shown in Fig. 5 (also see Fig. S1 in the
supplemental material), patterns of viRNAs mapping to the
SFV genome or antigenome were largely identical for the two
cell types, indicating that the generation of viRNAs is remark-
ably conserved between these two cell types from related but
different species. As expected, a direct comparison of viRNAs
FIG. 3. Characteristics of SFV-derived viRNAs in A. albopictus-derived U4.4 cells at 24 h p.i. (A) Size distribution of viRNAs in SFV-infected
U4.4 cells at 24 h p.i. Positive numbers on the y axis indicate the frequency of viRNAs mapping to the SFV genome (black boxes); negative numbers
on the y axis indicate the frequency of viRNAs mapping to the SFV antigenome (gray boxes). (B) Frequency distribution of 21-nt viRNA-
generating loci in the SFV genome (5 to 3; viRNAs starting with the 5 terminal nucleotide) or antigenome (3 to 5; viRNAs starting with the
3 terminal nucleotide), starting at nucleotide 1 on the x axis. Numbers on the y axis correspond to the frequencies of viRNAs mapping to the SFV
genome (positive) or antigenome (negative). Blue peaks indicate loci of viRNAs mapping to the SFV genome, and red peaks indicate loci of
viRNAs mapping to the SFV antigenome. A representative section is magnified (right) to highlight hot and cold spots in more detail. Virtually no
(131 SFV genome reads and 76 antigenome reads) sequences from uninfected control cells aligned to the SFV genome.
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from both U4.4 experiments (Tables S1 and S2) also shows
that the patterns and locations of viRNA hot spots and cold
spots are highly conserved between experiments, although read
frequencies can vary (Fig. S2).
Structural analysis of SFV genomic RNA and role of RNA
structures in viRNA generation. Previous work with plant-
infecting, positive-strand RNA viruses or viroids suggested that
double-stranded structures in the viral RNA can generate
viRNAs (20, 22, 36, 61). Little is known about the existence of
RNA structures in SFV genomic RNA; alphavirus genomes
are predicted to be mainly unstructured (11). However, struc-
tures in the 5 untranslated region of Venezuelan equine en-
cephalitis and Sindbis viruses, which influence replication in
mosquito cells, have been described (28, 40); structures in the
5 untranslated region have been predicted for all alphaviruses
(41); and stem-loop structures in the SFV 5 untranslated
region have been identified (30).
The secondary structure within the SFV genome was pre-
dicted by using large-scale thermodynamic prediction of min-
imal free energy (MFE) (50). MFE results are expressed as
MFE differences (MFED), that is, the percentage difference
between the MFE of the native sequence and the mean of a
scrambled control of the same sequence: MFED (%) 
[(MFEnative/MFEscrambled)  1]  100.
The MFED value provides a scale to quantify sequence
order-dependent RNA structure formation over the length of
the genome. Values plotted in Fig. 6A represent mean values
of five consecutive fragments. All nucleotide positions were
calculated relative to the SFV4 sequence.
As shown in Fig. 6A, MFED values approximate zero (equal
to or just above or below zero) for most of the SFV genome
(indicating an absence of structured RNA), with some excep-
tions, including the previously predicted region of known sec-
ondary structure at the 5 end. We compared the frequency
distribution of 21-nt genome-derived viRNAs (as shown in Fig.
3) with the pairing and MFED values (Fig. 6A). Statistical tests
to analyze the relationship between MFED values and viRNA
frequencies were done by using analysis of variance (ANOVA)
(Minitab, version 15) after categorizing viRNA frequencies as
follows: 1, 10, 10 to 100, and 100. The results showed that
there are no significant differences in MFED values across all
FIG. 4. Characteristics of SFV-derived viRNAs in A. aegypti-de-
rived Aag2 cells at 24 h p.i. (A) Size distribution of viRNAs in SFV-
infected Aag2 cells at 24 h p.i. Positive numbers on the y axis indicate
the frequency of viRNAs mapping to the SFV genome (black boxes);
negative numbers on the y axis indicate the frequency of viRNAs
mapping to the SFV antigenome (gray boxes). (B) Frequency distri-
bution of 21-nt viRNA-generating loci in the SFV genome (5 to 3;
viRNAs starting with the 5 terminal nucleotide) or antigenome (3 to
5; viRNAs starting with the 3 terminal nucleotide), starting at nucle-
otide 1 on the x axis. Numbers on the y axis correspond to frequencies
of viRNAs mapping to the SFV genome (positive) or antigenome
(negative). Blue peaks indicate loci of viRNAs mapping to the SFV
genome, and red peaks indicate loci of viRNAs mapping to the SFV
antigenome.
FIG. 5. Comparative analysis of SFV viRNA distribution profiles
from A. albopictus-derived U4.4 cells and A. aegypti-derived Aag2 cells
at 24 p.i. The x axis represents the SFV genome (5 to 3) (A) or
antigenome (3 to 5) (B), starting at nucleotide 1. For better compar-
isons of viRNA distribution along the SFV genome/antigenome loci in
two cell types, viRNA frequencies for each cell type were normalized
to their median 50% value (a comparison of the original distribution
and frequencies is shown in Fig. S1 in the supplemental material).
(A) Comparative analysis of viRNAs mapping to the SFV genome.
The y axis represents relative viRNA frequencies (positive, U4.4 cell-
derived viRNAs; negative, Aag2 cell-derived viRNAs). Blue peaks
represent U4.4 cell-derived viRNA loci; red peaks represent Aag2
cell-derived viRNA loci. (B) Comparative analysis of viRNAs mapping
to the SFV antigenome. The y axis represents relative viRNA frequen-
cies (positive, U4.4 cell-derived viRNAs; negative, Aag2 cell-derived
viRNAs). Blue peaks represent U4.4 cell-derived viRNA loci; red
peaks represent Aag2 cell-derived viRNA loci.
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designated levels of viRNAs (F  0.56; df  3, 10,882; P 
0.643). Secondary structures and paired regions (high proba-
bility of pairing indicated by values close or equal to 1) in the
SFV4 genome were predicted by using StructureDist (Fig. 6A).
The relationships between pairing values and viRNA frequen-
cies were analyzed by using Fisher’s exact tests (StatXact v8;
Cytel Software Corp., Cambridge, MA). viRNA frequencies
were placed into 4 categories (as described above). The pairing
values were categorized above or below cutoff values of 0.4 or
0.6 in two separate tests. The results show that there is no
significant association between pairing values and levels of
viRNAs (P  0.286 for a cutoff of 0.4; P  0.1147 for a cutoff
of 0.6).
Whereas there were no correlations across the whole data
set, there were nonetheless specific regions where predicted
secondary structures in the genome RNA were associated with
interesting viRNA patterns. Very high viRNA frequencies
were consistently (between experiments and cell types) associ-
ated with a genome region (nucleotides 204 to 258) between
two stem-loop structures (stem-loops with pairing values close
or equal to 1 indicated by green peaks in Fig. 6B; also repre-
sented in Fig. 7) predicted by using Mfold (33, 63). Clearly, a
high viRNA frequency does not always coincide with high
pairing or MFED values (Fig. 6B and C). A long-distance
pairing analysis of the genome identified 22 regions with com-
plementary sequences which could allow folding back to form
secondary structures. Analysis of the viRNA frequency indi-
cated that these regions produced no viRNAs or only a low
frequency of viRNAs.
siRNA mimics of hot-spot- and cold-spot-derived viRNAs
differ in their abilities to inhibit SFV replication. The ability to
interfere with virus replication of 21-nt siRNAs matching hot
or cold spots on the SFV genome (see Table 1 for sequences,
genome locations, and frequencies) was tested by using SFV
expressing a Renilla luciferase (RLuc) reporter gene,
SFV4(3H)-RLuc (Fig. 1). This reporter virus encoded RLuc
(flanked by duplicated nsP2-protease cleavage sites at the
nsP3/4 junction) as part of the viral nonstructural polyprotein;
RLuc activity is an accurate readout for SFV replication, virus
production, and spread in mosquito cells (3, 15, 27). siRNA
mimics of viRNAs were matched according to the viRNAs
described in the legend to Fig. 3 (see Table S1 in the supple-
mental material for details); hot- and cold-spot conservation
was confirmed with other SFV viRNA distribution profiles
from U4.4 or Aag2 cells, such as those shown in Fig. 4 and 5
FIG. 6. (A) Prediction of RNA secondary structures and pairing within the SFV genome by MFED and StructureDist bioinformatic analysis
and correlation to the 21-nt viRNA frequency in U4.4 cells. viRNAs described in the legend to Fig. 3 were used for this analysis. The distribution
of MFED and pairing values (right y axis) along the SFV genome (x axis, starting at nucleotide 1) are shown as a red line and green shadow,
respectively. High positive MFED values suggest areas with RNA secondary structures, while values around 0 or negative do not. Pairing values
close to or equal to 1 suggest paired regions and secondary structures, whereas low pairing values indicate an absence of pairing. For the clarity
of the figure, ascending values on the right y axis are indicated from top to bottom. viRNA frequencies on locations along the SFV genome (blue
peaks) are indicated on the left y axis. (B, C, and D) Magnifications of selected regions from A.
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(Table 1, and see Tables S2 and S3 in the supplemental ma-
terial for details).
Biologically active viRNAs targeting the viral genome
should mediate the degradation of viral RNA and thus reduce
RLuc expression. U4.4 cells were transfected with siRNA mim-
ics of hot- and cold-spot genome viRNAs (7 hot or cold spots;
final concentration, 10 nM) for 24 h and then infected at an
MOI of 1 with SFV4(3H)-RLuc, and RLuc activities were
determined at 12 h p.i. As shown in Fig. 8, the overall ability of
cold-spot viRNA mimics to inhibit SFV replication is signifi-
cantly higher than that of hot-spot viRNA mimics (P  0.05 by
a statistical comparison of hot- and cold-spot-derived siRNA
mimic activities by a Mann-Whitney U test). siRNA concen-
tration ranges from 3.125 to 100 nM were tested for selected
siRNAs, and siRNA mimics of viRNAs maintained their indi-
vidual characteristics at various concentrations; i.e., siRNA
mimics of hot-spot viRNAs generally displayed no or poor
antiviral activity, while antivirally active siRNA mimics of cold-
spot viRNAs also showed activity at 3.125 nM (data for three
siRNA mimics of both hot- and cold-spot viRNAs as well as
controls are shown in Fig. S3 in the supplemental material).
Experiments with siRNA mimics of hot- and cold-spot
viRNAs were repeated with A. aegypti-derived Aag2 cells as de-
scribed above, and the same effects were obtained (see Table 1
for comparison), with siRNA mimics of cold-spot viRNAs
again being significantly more efficient than siRNA mimics of
hot-spot viRNAs (P  0.05 by a Mann-Whitney U test) at
inhibiting SFV replication (Fig. 9). This demonstrates that our
observations extend to cells derived from a related mosquito
species.
DISCUSSION
RNAi is a major defense mechanism against arboviruses
in mosquitoes (14, 38). However, surprisingly little is known
about the dsRNA substrate for dicer and the origin of
dsRNA-derived viRNAs which mediate the degradation of virus
target RNA. To address this, we describe the application of
deep-sequencing technology to SFV-infected A. albopictus
U4.4 cells to characterize SFV-derived viRNAs produced dur-
ing the acute phase of infection. Very noticeable hot spots of
viRNA generation were identified along the length of the SFV
genome and antigenome, while cold spots that generated no
detectable or few viRNAs were also present. This is in agree-
ment with previous findings with A. aegypti and Anopheles
gambiae mosquitoes infected with alphaviruses and suggests
that key features of alphavirus-induced antiviral RNAi are
conserved within aedine and anopheline mosquitoes (38, 39).
Moreover, similar viRNA distributions were observed for in-
fections of mosquitoes with a flavivirus, West Nile virus (4).
Together with a growing body of experimental evidence, our
results support the hypothesis that alphaviruses do not encode,
unlike many known insect-only viruses, protein-based RNAi
inhibitors (14).
The nature of alphavirus-induced dsRNAs that give rise
to viRNAs is not clear, although that is a key question in the
FIG. 7. RNA secondary structures in the 5 region of the SFV4
genome, as predicted by Mfold. Numbers indicate positions of nucle-
otides in the SFV4 genome.
FIG. 8. Synthetic siRNA mimics of SFV genome hot-and cold-spot
viRNAs (see Table 1 for details) and their effects on virus replication.
A. albopictus-derived U4.4 cells were transfected with siRNAs (includ-
ing a positive-control siRNA targeting RLuc [pos] and a negative-
control scrambled siRNA [neg] [final concentration, 10 nM]) for 24 h
and then infected with the reporter SFV4(3H)-RLuc (Fig. 1) at an
MOI of 1. Following this step, RLuc activities (readout for SFV rep-
lication) were determined at 12 h p.i. and compared to that of nega-
tive-control scrambled siRNA (100% relative RLuc expression). Sta-
tistical analysis was performed by comparing the activities of hot- and
cold-spot mimic siRNA groups (P  0.05 by a Mann-Whitney U test).
This experiment was performed in triplicate for each siRNA and re-
peated three times; bars show the average relative RLuc activities for
each siRNA from all three experiments, and error bars represent
standard errors.
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understanding of viRNA distribution. One possibility is that,
as with some plant viruses, RNA secondary structures could
serve as substrates for dicer (20–22, 36). MFED and pairing
analyses of the SFV genome delineate secondary structures
at the 5 end. The remainder of the genome contained only
a few areas with a high probability of secondary structures.
The lack of any correlation between the frequency of 21-nt
viRNA production and regions of conserved base pairing
indicates that the vast majority of viRNAs are not specifi-
cally targeted to genome secondary structures. Alphavirus
viRNAs are therefore derived mainly from virus-induced
dsRNAs, such as dsRNA replication intermediates, in line
with a previously reported hypothesis (38); indeed, other
arbovirus-derived small RNAs (resembling piwi-interacting
RNAs [piRNAs]) in mosquito cells are prominent only in
RNAi-deficient cell lines (5, 49). Although structures at the
3 terminus of the flavivirus genome have been character-
ized in the past, these structures do not appear to be par-
ticularly targeted by the RNAi response or generate excess
viRNAs during mosquito infection by West Nile virus (4). It
therefore remains unclear how viRNAs are distributed into
hot spots and cold spots. Areas that repeatedly generate
hot-spot viRNAs may be in a conformation (pairing struc-
tures?) that favors the interaction with Dcr-2, although we
did not observe a particular bias in dsRNA stability between
hot-spot and cold-spot viRNAs by bioinformatics analysis
(our unpublished observations). Those locations that gen-
erate few or no viRNAs (nonpairing structures?) may not favor
those interactions, or cold spots could be shielded from the
RNAi machinery. These two different conformations may work
in opposite ways for target recognition by RISC, and hot-spot
viRNAs would not silence SFV gene expression/replication as
well as cold-spot viRNAs. The reason why hot-spot or cold-
spot viRNAs do not uniquely act in the same way may also be due
to the influence from tertiary and quaternary structures, as was
described previously for siRNA targeting of hepatitis C virus
(43). Our results with cold-spot viRNAs could also inform the
choice of siRNAs as therapeutics against alphaviruses if similar
findings are obtained for vertebrate cells.
Our results show that SFV does not inhibit the generation
of viRNAs and that these viRNAs are generated in hot spots
mainly along the SFV genome but also the antigenome.
Presently, much information about the biology of viRNAs in
insect cells stems from D. melanogaster flies and cells in-
fected with a positive-strand RNA insect virus, flock house
virus (FHV) (Nodaviridae) (1, 13, 56). In D. melanogaster
cells latently infected with FHV, viRNAs are generated
from dsRNA replication intermediates, which act as the
main substrate for Drosophila Dcr-2 activity; again, viRNAs
were derived from the entire FHV genome but with hot
spots particularly at the 5 ends of the bipartite FHV ge-
nome (13). We demonstrate that hot-spot-derived viRNAs,
the predominant type of viRNA, are far less effective at
silencing SFV replication than are cold-spot viRNAs. We
suggest that alphaviruses, which do not appear to encode
generally active suppressors of RNAi, might have evolved in
this direction to produce decoy viRNAs that might hinder
the RNAi machinery and allow the virus time to replicate
before it is eventually silenced through RNAi. Hot-spot-
derived viRNAs in D. melanogaster cells latently infected
with FHV also display poor biological activities (13), similar
to findings described in this study. In the case of FHV it was
also found that the bulk of viRNAs were not loaded into
Ago-2, which might account for the lack of silencing activity,
although direct dicing of replication intermediates could
also mediate antiviral activity (13). This might indeed sug-
gest a genome nucleic acid-mediated resistance to RNAi,
which allows limited replication without the need of a viral
suppressor of RNAi (VSR). In particular, for alphaviruses,
where the coexpression of powerful RNAi-inhibitory pro-
teins has been shown to dramatically decrease mosquito
survival, a viRNA-based decoy mechanism might be enough
to maintain the delicate balance between arbovirus replica-
tion and vector survival (9, 39). At least in the case of a
potato spindle tuber viroid, resistance to RNAi based solely
on genome secondary structures has been identified; viroid-
derived siRNAs stem mostly from secondary structures
within the viroid RNA; however, these secondary structures
are in turn highly resistant to RISC-mediated cleavage (22).
Adenoviruses of vertebrates express RNAs that suppress
RNAi (2, 31). West Nile virus appears to evade RNAi in
vertebrate cells by making replication complexes inaccessi-
ble to the RNAi machinery, and similar evasion strategies
have been suggested for alphaviruses (16, 18, 24); indeed,
we showed (Fig. 2) that in the early acute phase, dsRNA is
very closely associated with replication complexes. Strate-
gies other than protein-based RNAi inhibitors may there-
FIG. 9. Synthetic siRNA mimics of SFV genome hot- and cold-
spot viRNAs (see Table 1 for details) and their effects on virus
replication. A. aegypti-derived Aag2 cells were transfected with
siRNAs (including a positive-control siRNA targeting RLuc [pos]
and a negative-control scrambled siRNA [neg] [final concentration,
10 nM]) for 24 h and then infected with the reporter SFV4(3H)-
RLuc (Fig. 1) at an MOI of 1. Following this step, RLuc activities
(readout for SFV replication) were determined at 12 h p.i. and
compared to that of negative-control scrambled siRNA (100% rel-
ative RLuc expression). Statistical analysis was performed by com-
paring the activities of hot- and cold-spot mimic siRNA groups (P
 0.05 by a Mann-Whitney U test). This experiment was performed
in triplicate for each siRNA and repeated three times; bars show the
average relative RLuc activities for each siRNA from all three
experiments, and error bars represent standard errors.
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fore be employed by arboviruses to limit the effects of mos-
quito antiviral RNAi responses.
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